Vimarsana
Biggest News Aggregation in the World

Frederickl Ruberg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Frederickl Ruberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Frederickl Ruberg Today - Breaking & Trending Today

BridgeBio Pharma : BBIO – Acoramidis AG10 TTR – ISA 2024 – Acoramidis treatment related increase in serum TTR is associated with lower cardiovascular mortality in ATTR CM - Vimarsana News

BridgeBio Pharma : BBIO – Acoramidis AG10 TTR – ISA 2024 – Acoramidis treatment related increase in serum TTR is associated with lower cardiovascular mortality in ATTR CM

Treatment-Related Early Increase in Serum TTR is Associated With Lower Cardiovascular Mortality in ATTR-CM: Insights From ATTRibute-CM Amrut...

Blood test may help identify patients at risk for transthyretin amyloid cardiomyopathy - Vimarsana News

Blood test may help identify patients at risk for transthyretin amyloid cardiomyopathy

A new multi-center study led by doctors at Boston Medical Center and Columbia University found that having a genetic variant in the prealbumin gene alone is not sufficient for diagnosis of transthyretin amyloid cardiomyopathy in older Black patients.

ACC Issues Expert Consensus Decision Pathway on Cardiac Amyloidosis - Vimarsana News

ACC Issues Expert Consensus Decision Pathway on Cardiac Amyloidosis

The American College of Cardiology (ACC) has published its “2023 ACC Expert Consensus Decision Pathway on Comprehensive Multidisciplinary Care for the Patient with Cardiac Amyloidosis” in the Journal of the American College of Cardiology.